AK Forte Ortiga y Omega 3 Cont — Class II drug recall D-0024-2025
Ongoing recall by C & A Naturistics, reported 2024-10-30, distributed nationwide. Marketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac
| Recall number | D-0024-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | C & A Naturistics, National City, CA, United States |
| Recall initiated | 2024-10-08 |
| Classified | 2024-10-22 |
| Reported by FDA | 2024-10-30 |
| Distributed | Nationwide (US) |
| Reason classes | undeclared allergen, unapproved product |
Product
AK Forte Ortiga y Omega 3 Cont. Neto 100 Tabletas, 400 mg,
Reason for recall
Marketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac and acetaminophen.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0024-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.